Concepedia

Robert Henningsen

RH

Statistics

Publications

22

Citations

3.5K

H-Index

19

Active since

1989

Affiliations

Roche (Switzerland)(Current)

Sutro Biopharma (United States)

Roche (United States)

La Roche College

Oregon Health & Science University

Robert Henningsen is an author at Roche (Switzerland) specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

1989–2023

22

Publications

22

Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor

Rainer K. Reinscheid, Hans‐Peter Nothacker, Anne Bourson et al. · Science · 1995 · 1.8K citations

Primary structure and tissue distribution of the orphanin FQ precursor.

Hans‐Peter Nothacker, Rainer K. Reinscheid, Alfred Mansour et al. · Proceedings of the National Academy of Sciences · 1996 · 251 citations · Full text

, , +18

Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.

Kim A. Neve, Barbara Cox, Robert Henningsen et al. · Molecular Pharmacology · 1991 · 195 citations

Release of dopamine via the human transporter.

Amy J. Eshleman, Robert Henningsen, Kim A. Neve et al. · Molecular Pharmacology · 1994 · 155 citations

AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist

Joel R. Gever, Rothschild Soto, Robert Henningsen et al. · British Journal of Pharmacology · 2010 · 126 citations · Full text

1–5 of 22